Docetaxel (Hospira, Inc.)


Welcome to the PulseAid listing for the Docetaxel drug offered from Hospira, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: DOCETAXEL ANHYDROUS
SUBSTANCE NAME: DOCETAXEL ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-03-17
END MARKETING DATE: 0000-00-00


Docetaxel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDocetaxel from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2011-03-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-0201_4302270d-579f-4f7f-9ec1-892caeb236ee
PRODUCT NDC: 0409-0201
APPLICATION NUMBER: NDA022234

Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Docetaxel
Hospira, Inc.Docetaxel
Ingenus Pharmaceuticals, LLCDOCETAXEL
McKesson Packaging Services a business unit of McKesson CorporationDocetaxel
Northstar RxLLCDocetaxel
Sagent PharmaceuticalsDocetaxel
Teva Parenteral Medicines, Inc.Docetaxel